|
| |
BioPortfolio's Approved Drugs DatabaseNasacortTriamcinolone AcetonideDownload PDF containing detailed information.
Press Releases About Nasacort:
|
 |
| Sanofi-aventis Delivers a Solid Performance in Third Quarter 2009 |
30th October, 2009 |
sanofi-aventis |
2009 Q3 Change Change at 2009 Change Change at
on a constant 9 months on a constant
reported
|
| Aventis Pharmaceutical to Pay U.S. $95.5 Million to Settle False Claims Act Allegations |
28th May, 2009 |
U.S. Department of Justice |
WASHINGTON, May 28 /PRNewswire-USNewswire/ -- Aventis Pharmaceutical Inc., a wholly owned subsidiary of sanofi-aventis U.S. LLC, has agreed to pay the United States $95.5 million to settle allegations
|
| Sanofi-aventis Delivers 2008 Results Above Guidance |
11th February, 2009 |
sanofi-aventis |
FY 2008 % change Q4 2008 % change
------- -------- ------- --------
Comparable net sales*: EUR27,568m
|
| Sanofi-aventis News |
31st July, 2008 |
sanofi-aventis |
PARIS, July 31 /PRNewswire-FirstCall/ -- Sanofi-aventis announces solid
growth in the second quarter.
Solid growth in the second quarter
-- Net sales: euro 6,689m, up 5.2% on a
|
This page has been viewed 26 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Nasacort across BioPortfolio, or for Nasacort Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|